Valutazione Metabolica Della Nefrolitiasi Calcica

Smith L.H. The medical aspects of urolithiasis: an overview. J Urol 1989; 141: 707–10.

Marangella M. Metabolic evaluation of calcium nephrolithiasis. J Nephrol 1995; 8: 179–84.

Marangella M. , Bruno M. , Cosseddu D. Prevalence of chronic renal insufficiency in the course of idiopathic calcium stone disease: risk factors and patterns of progression. Nephron 1990; 54: 302–6.

Pak C.Y.C. Role of medical prevention. J Urol 1989; 141: 789–801.

Coe Fl , Favous M.J. Disorders of stone formation. In: Brenner B. , Rector F.C. eds. The Kidney, 3rd ed. Philadelphia: WB Saunders Co. 1986: 1403–42.

Broadus A.E. , Thier S.O. Metabolic basis of renal stone disease. N Engl J Med 1979; 300: 839–43.

Pak C.Y.C. , Britton F. , Peterson R. Ambulatory evaluation of nephrolithiasis: classification, clinical presentation and diagnostic criteria. Am J Med 1980; 69: 19–22.

Kumar S. , Sigmon D.H. , Miller T. A new model of nephrolithiasis involving tubular dysfunction/injury. J Urol 1991; 146: 1384–9.

Ginalski J.M. , Spiegel T.H. , Jaeger P.H. Does medullary sponge kidney cause nephrolithiasis. Am J Radiol 1990; 155: 299–302.

Baggio B. , Gambaro G. , Marchini F. , Cicerello G. , Borsatti A. Raised transmembrane flux in red blood cells in idiopathic calcium oxalate nephrolithiasis. Lancet 1984; ii: 11–4.

Kok D.J. , Khan S.R. Calcium oxalate nephrolithiasis, a free or fixed particle disease. Kidney Int 1994; 46: 847–54.

Bianchi G. , Vezzoli G. , Cusi D. Abnormal red-cell calcium pump in patients with idiopathic hypercalciuria. N Engl J Med 1988; 319: 897–901.

Parks J.H. , Coe F.L. A urinary calcium-citrate index for the evaluation of nephrolithiasis. Kidney Int 1986; 30: 85–90.

Robertson W.G. , Peacock M. , Nordin B.E.C. Activity product in stone-forming and non-stone-forming urine. Clin Sci 1968; 34: 579–94.

Preminger G.M. The metabolic evaluation of patients with recurrent nephrolithiasis: a review of comprehensive and simplified approaches. J Urol 1989; 141: 760–3.

Petrarulo M. , Bianco O. , Martini C. , Marangella M. , Linari F. Dosaggio degli ioni solfato e fosfato urinari mediante cromatografia ionica. Giorn It Chim Clin 1985; 10: 276–9.

Petrarulo M. , Marangella M. , Bianco O. Preventing ascorbate interference in the ion-chromatographic detrmination of oxalate: four methods compared. Clin Chem 1990; 36: 1642–5.

Marangella M. , Daniele P.G. , Ronzani M. Urine saturation with calcium salts in normal subjects and idiopathic calcium stone formers estimated by an improved computer modelsystem. Urol Res 1985; 13: 189–93.

Hosking D.H. , Erickson S.B. , Van den Berg C.J. , Wilson D. , Smith L.H. The stone clinic effect in patients with idiopathic calcium urolithiasis. J Urol 1983; 130: 115–9.

Pak C.Y.C. , Oata M. , Lawrence E.C. , Snyder W. The hypercalciurias: causes, parathyroid functions, and diagnostic criteria. J Clin Invest 1974; 54: 387–400.

Coe F.L. , Parks J.H. , Asplin J.R. The pathogenesis and treatment of kidney stones. N Engl J Med 1992; 327: 1141–52.

Smith L.H. Diet and hyperoxaluria in syndrome of idiopathic calcium urolithiasis. Am J Kidney Dis 1991; 17: 370–5.

Muldowney F.P. , Freaney R. , Moloney M.F. Importance of dietary sodium in the hypercalciuria syndrome. Kidney Int 1982; 22: 292–6.

Daniele P.G. , Sonego S. , Ronzani M. , Marangella M. Ionic strength dependence of formation constants. Solubility of calcium oxalate monohydrate and calcium hydrogenphosphate dihydrate in aquaeus solution, at 37° C and different ionic strength. Annali Chimica 1985; 75: 245–51.

Pietschmann F. , Breslau N.A. , Pak C.Y.C. Reduced vertebral bone density in hypercalciuric nephrolithiasis. J Bone Min Res 1992; 7: 1383–8.

Linari F. , Marangella M. , Vitale C. , Cosseddu D. Effetti a lungo termine della terapia medica della nefrolitiasi calcica sul metabolismo minerale. It J Min Elect Met 1992; 6: 89–96.

Ray W.A. , Griffin M.R. , Downey W. , Melton L.J. III Long-term use of phiazide diuretics and risk of hip fracture. Lancet 1989; i: 687–90.

Rao P. , Jenkins I.L. , Robertson W.G. , Peacock M. , Blacklock N.J. The effect of high fibre biscuit on urinary risk factors for stone formation. In: Schwüle P.O. , Smith L.H. , Robertson W.G. , Vahlensieck W. eds. Urolithiasis and related clinical research. New York: Plenum Press, 1985; 425–8.

Lemann J. Jr. , Gray R.W. Idiopathic hypercalciuria. J Urol 1989; 141: 715–8.

Robertson W.G. , Morgan D.B. The distribution of urinary calcium excretions in normal persons and stone formers. Clin Chim Acta 1972; 37: 503–10.

Lemann J. Jr. Urinary calcium excretion and net acid excretion: effects of dietary proteins, carbohydrate and calories. In: Schwüle P.O. , Smith L.H. , Robertson W.G. , Vahlensieck W. eds. Urolithiasis and related clinical research. New York: Plenum Press, 1985; 53–9.

Lemann J. Jr. , Gray R.W. Hypercalciuric kidney stone formers exhibit enhanced intestinal calcium absorption despite only slightly elevated 1,25(OH)₂-D concentrations. Kidney Int 1988; 33: 343 (abstract).

Sutton R.A.L. , Walker V.R. Bone resorption and hypercalciuria in calcium stone formers. Metabolism 1986; 35: 485–8.

Robertson W.G. , Peacock M. The cause of idiopathic calcium stone disease: hypercalciuria or hyperoxaluria? Nephron 1980; 26: 105–10.

Baggio B. , Gambaro G. , Favaro S. , Borsatti A. Prevalence of hyperoxaluria in idiopathic calcium oxalate kidney stone disease. Nephron 1983; 35: 11–6.

Marangella M. , Petrrulo M. , Vitale C. , Cosseddu D. , Linari F. Plasma and urine glycolate assays for differentiating the hyperoxaluria syndromes. J Urol 1992; 148: 986–9.

Marangella M. , Petrarulo M. Oxalate measurement in biological fluids. In: Khan S.R. ed. Calcium oxalate in biological systems. New York: CRC Press, 1995, cap. 12, pp. 239–63.

Williams H.E. , Wandzilak T.R. Oxalate synthesis, transport and the hyperoxalurica syndromes. J Urol 1989; 141: 742–7.

Danpure C.J. , Jennings P.R. , Watts R.W.E. Enzymological diagnosis of primary hyperoxaluria type 1 by measurement of hepatic alanine: glyoxylate aminotransferase activity. Lancet 1987; i: 289–91.

Williams H.E. , Smith L.H. Jr. L-glyceric aciduria. A new genetic variant of primary hyperoxaluria. N Engl J Med 1968; 278: 233–9.

Robertson W.G. , Heyburn P.J. , Peacock M. The effect of high animal protein intake on the risk of calcium stone-formation in the urinary tract. Clin Sci 1979; 57: 285–8.

Marangella M. , Bianco O. , Martini C. , Petrarulo M. , Vitale C. , Linari F. Effect of animal and vegetal protein intake on oxalate excretion in idiopathic calcium stone disease. Br J Urol 1989; 63: 348–51.

Schmidt K.H. , Hagmaier V. , Hornig D.H. , Vuilleumier J.P. , Rutishauser G. Urinary oxalate excretion after large intakes of ascorbic acid in man. Am J Clin Nutr 1981; 34: 305–9.

Wanszilak T.R. , D'Andre S.D. , Davis P.A. , Williams H.E. Effect of high dose vitamine C on urinary oxalate levels. J Urol 1994; 151: 834–8.

Gill H.S. , Rose G.A. Mild metabolic hyperoxaluria and its response to pyridoxine. Urol Int 1986; 41: 393–6.

Marangella M. , Bruno M. , Fruttero B. , Linari F. Hyperoxaluria in idiopathic calcium stone-disease: further evidence of intestinal hyperabsorption of oxalate. Clin Sci 1984; 63: 381–5.

Earnest D.L. , Johnson G. , Williams H.E. , Admirand W.H. Hyper-oxaluria in patients with ileal resection: an abnormality of dietary oxalate absorption. Gastroenterology 1974; 66: 1114–22.

Petrarulo M. , Pellegrino S. , Bianco O. , Marangella M. , Linari F. , Mentasti E. Derivatization and high performance liquid chromatographic determination of urinary glycolic acid. J Chromatogr 1989; 465: 87–93.

Petrarulo M. , Marangella M. , Cosseddu D. , Linari F. High- performance liquid chromatographic assay for L-glyceric acid in body fluids. Application in primary hyperoxaluria type 2. Clin Chim Acta 1992; 211: 143–53.

Williams D.G. Methods for the estimation of three vitamin dependent red cell enzymes. Clin Biochem 1976; 9: 252–6.

Gambaro G. , Petrarulo M. , Nardelotto A. , Marangella M. , Baggio B. Erythrocyte transmembrane flux and renal clearance of oxalate in idiopathic calcium nephrolithiasis. Kidney Int 1995; 48: 1549–52.

Kok D.J. , Papapoulos S.E. , Bijvoet O.L.M. Eccessive crystal agglomeration with low citrate excretion in recurrent stone-formers. Lancet 1986; i: 1056–8.

Simpson D.P. Citrate excretion: a window on renal metabolism. Am J Physiol 1983; 244: F223–34.

Marangella M. , Vitale C. , Manganare M. Renal handling of citrate in chronic renal insufficiency. Nephron 1991; 57: 439–43.

Marangella M. , Bianco O. , Grande M.L. Patterns of citrate excretion in healthy subjects and patients with idiopathic stone disease. Contr Nephrol. 58, Karger, Basel 1987; 34–8.

Vitale C. , Marangella M. , Cosseddu D. , Bianco O. , Linari F. Mechanisms of hypocitraturia in idiopathic calcium stone disease. In: Walker V.R. , Sutton R.A.L. , Cameron E.C.B. , Pak C.Y.C. , Robertson W.G. eds. Urolithiasis. New York: Plenum Publishing Co. 1989, 501–2.

Nicar M.J. , Skurla C. , Sakhaee K. , Pak C.Y.C. Low urinary citrate excretion in nephrolithiasis. Urology 1983; 21: 8–14.

Preminger G.M. , Sakhaee K. , Skurla C. , Pak C.Y.C. Prevention of recurrent calcium stone formation with potassium citrate therapy in patients with distal renal tubular acidocis. J Urol 1985; 134: 20–3.

Pak C.Y.C. Citrate and renal calculi: new insights and future directions. Am J Kidney Dis 1991; 17: 420–5.

Oh M.S. A new method for estimating GI absorption of alkali. Kidney Int 1989; 36: 915–7.

Gutman A.B. Uric acid nephrolithiasis. Am J Med 1968; 45: 756–79.

Coe F.L. Uric acid and calcium oxalate nephrolithiasis. Kidney Int 1983; 24: 392–403.

Coe F.L. , Kavalach A.G. Hypercalciuria and hyperuricosuria in patients with calcium nephrolithiasis. N Engl J Med 1974; 291: 1344–50.

Pak C.Y.C. , Waters O. , Arnold L.R. , Holt K. , Cox C. , Barilla D. Mechanism of calcium urolithiasis among patients with hyperuricosuria. J Clin Invest 1977; 59: 426–31.

Coe F.L. , Strauss A.L. , Tembe V. , Le Dun S. Uric acid saturation in calcium nephrolithiasis. Kidney Int 1980; 17: 662–8.

Finlayson B. , Reid F. The effect of allopurinol on calcium oxalate (whewhellite) precipitation. Invest Urol 1978; 15: 489–92.

Coe F.L. Calcium-uric acid nephrolithiasis. Arch Intern Med 1978; 138: 1090–3.

Pak C.Y.C. , Holt K. Nucleation and growth of brushite and calcium oxalate in urine of stone formers. Metabolism 1976; 25: 665–73.

Kaiser E.T. , Bock S.C. Protein inhibitors of crystal growth. J Urol 1989; 141: 750–2.

Robertson W.G. , Peacock M. , Marshall R.W. , Marshall D.H. , Nordin B.E.C. Saturation-inhibition index as a measure of the risk of calcium oxalate stone-formation in the urinary tract. N Engl J Med 1976; 294: 249–52.

Coe F.L. , Nakagawa Y. , Parks J.H. Inhibitors within the nephron. Am J Kidney Dis 1991; 17: 407–13.

Mandel N. , Riese R. Crystal-cell interactions: crystal binding to rat renal papillary tip collecting duct cells in culture. Am J Kidney Dis 1991; 17: 407–13.

Khan S.R. , Finlayson B. , Hackett R.L. Experimental calcium oxalate nephrolithiasis, role of renal papilla. Am J Pathol 1982; 107: 5–69.